Drug
Chk336
Chk336: highest development phase Phase 1, developed by Chinook Therapeutics. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Chinook Therapeutics
Trials
| Drug | Phase | Indication |
|---|---|---|
| CHK336 NCT05367661 | Phase 1 | Healthy Volunteers |
Latest
No recent events.
Follow Chk336 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.